Agios Pharmaceuticals
AGIO
AGIO
206 hedge funds and large institutions have $2.58B invested in Agios Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 78 increasing their positions, 68 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.28% less ownership
Funds ownership: 102.4% → 102.12% (-0.28%)
15% less call options, than puts
Call options by funds: $17.8M | Put options by funds: $21.1M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
206
Holding in Top 10
2
Calls
$17.8M
Puts
$21.1M
Top Buyers
| 1 | +$44.5M | |
| 2 | +$33.8M | |
| 3 | +$9.62M | |
| 4 |
CCM
Cutter Capital Management
New York
|
+$8.29M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$7.65M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$19.2M | |
| 3 | -$15.3M | |
| 4 |
Morgan Stanley
New York
|
-$11M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$10.7M |